Stocks and Investing Stocks and Investing
Wed, April 17, 2024
[ 12:00 AM ] - WOPRAI
Chris Kotowski Maintained (BAC) at Buy with Decreased Target to $45 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Chris Olin Downgraded (BA) to Strong Sell and Held Target at $140 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Nathan Jones Maintained (AOS) at Hold with Increased Target to $91 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Elizabeth Porter Maintained (AMPL) at Sell with Decreased Target to $10 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Noah Kaye Maintained (AMRC) at Hold on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Youssef Squali Maintained (AMZN) at Strong Buy with Increased Target to $216 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Tom Forte Initiated (AMZN) at Strong Buy and Held Target at $218 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Ronald Jewsikow Maintained (AN) at Strong Buy with Increased Target to $169 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Sarah Barcomb Maintained (BXMT) at Strong Buy with Decreased Target to $22 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (BX) at Buy with Increased Target to $145 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Joseph Feldman Reiterated (ACI) at Hold and Held Target at $27 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Justin Walsh Initiated (ACHV) at Strong Buy and Held Target at $20 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Tom Forte Initiated (AAPL) at Hold and Held Target at $178 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Douglas Tsao Reiterated (aeon) at Strong Buy and Held Target at $18 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Nicholas Jones Reiterated (ACVA) at Buy and Held Target at $19 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Ryan Koontz Reiterated (ADTN) at Strong Buy and Held Target at $8 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Adam Borg Maintained (ADSK) at Strong Buy and Held Target at $316 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Elizabeth Porter Maintained (ZI) at Hold with Decreased Target to $18 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Yi Fu Lee Reiterated (ZS) at Hold and Held Target at $230 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Nathan Jones Maintained (WTS) at Hold with Increased Target to $209 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (wt) at Hold with Increased Target to $9.25 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Andres Cardona Downgraded (YPF) to Hold and Increased Target to $24 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Elizabeth Porter Maintained (WIX) at Hold with Decreased Target to $143 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Jon Tower Maintained (WING) at Hold with Increased Target to $375 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Wamsi Mohan Maintained (WDC) at Strong Buy with Increased Target to $85 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Ashwin Shirvaikar Maintained (WEX) at Strong Buy with Increased Target to $280 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (VRTS) at Sell with Increased Target to $224 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Colin Bristow Maintained (VRTX) at Strong Buy with Decreased Target to $466 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Nathan Jones Maintained (vlto) at Strong Buy with Increased Target to $97 on, Apr 17th, 2024
[ 12:00 AM ] - WOPRAI
Hartaj Singh Maintained (VIRX) at Buy and Held Target at $13 on, Apr 17th, 2024

Hartaj Singh Maintained (VIRX) at Buy and Held Target at $13 on, Apr 17th, 2024


Published on 2024-10-28 10:25:25 - WOPRAI, Hartaj Singh
  Print publication without navigation


Hartaj Singh of Oppenheimer, Maintained "Viracta Therapeutics, Inc." (VIRX) at Buy and Held Target at $13 on, Apr 17th, 2024.

Hartaj has made no other calls on VIRX in the last 4 months.



There is 1 other peer that has a rating on VIRX. Out of the 1 peers that are also analyzing VIRX, 0 agree with Hartaj's Rating of Hold.



This is the rating of the analyst that currently disagrees with Hartaj

  • Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $4 on, Tuesday, April 16th, 2024
Contributing Sources